G

A

GONCALVES , Anthony

Last name: GONCALVES

First name: Anthony

May 20, 2021 (v1)

Journal article

Metadata-only

Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program.

Bertucci, F. Bello, Diana Bertucci, Alexandre

1064 Background: In 11.2018, the PIK3CA-inhibitor alpelisib was made available in France through an early access program (EAP), in combination with fulvestrant in pre-treated PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer (ABC) patients. Patients had to received two or more prior systemic treatments for ABC, including an...

Uploaded on: December 3, 2022
March 2023 (v1)

Journal article

Metadata-only

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort

Collet, Laetitia Eberst, Lauriane Ludovic, Gauthier

Background: More than 10% of HER2-positive metastatic breast cancer (mBC) will develop Central Nervous System (CNS) metastases as first and isolated site of relapse on trastuzumab and pertuzumab first-line therapy. However, few clinical data are available to guide the best strategy in this setting.Methods: Patients experiencing isolated CNS...

Uploaded on: September 26, 2024